Bayer sales & distribution arrangement to expire on 31st December, 2026; will not be renewed

Piramal Pharma's distribution arrangement with Bayer Pharmaceuticals will expire on 31st December, 2026 and will not be renewed.

Thu 1 Oct 2026

Counterparty

Bayer Pharmaceuticals Private Limited

Contract Expiry Date

31st December, 2026

Contract Renewal Status

will not be renewed beyond its current term

Revenue Contribution

less than 5% of the company's consolidated revenue

Expected Impact

does not expect the non-renewal to have a material impact on its profitability or financial position

Expiry of a distribution arrangement

Piramal Pharma has informed the exchanges that the commercial arrangement under which it provides sales and distribution support services to Bayer Pharmaceuticals Private Limited is scheduled to expire on 31st December, 2026.

• The distribution arrangement will not be renewed beyond its current term.
• It will conclude upon its natural expiry on 31st December, 2026.
• The company is working closely with Bayer to ensure a smooth and orderly transition of the activities currently undertaken under the arrangement.

What the company earned from it

The arrangement primarily involved the provision of sales and distribution support services by the company, for which the company earned a commission-based income.

How big the revenue is

• Revenue attributable to this arrangement accounts for less than 5% of the company's consolidated revenue.
• As the arrangement is commission-based in nature, the company does not expect the non-renewal to have a material impact on its profitability or financial position.

In simple terms

• The arrangement runs until its stated expiry date of 31st December, 2026.
• After that date it stands concluded, since it will not be renewed beyond the current term.
• The company's stated expectation is that profitability and financial position are not materially affected, given the commission-based nature of the income and the size of the revenue involved.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.